NFIL

Mumbai, India Founded: 1967 • Age: 59 yrs Listed India's Most Valuable
Fluorinated compounds are synthesized and manufactured customly for various industries.

About NFIL

NFIL is a publicly listed company based in Mumbai (India) founded in 1967. Fluorinated compounds are synthesized and manufactured customly for various industries. The company has 2,670 employees. Its website nfil.in draws about 10 thousand monthly visits. Its Indian entity Navin Fluorine International Limited reported revenue of β‚Ή3,379 Cr. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry.

Company details

Navin Fluorine International Limited (NFIL) is a CRAMS company engaged in the research and synthesis of fluorinated compounds for the pharmaceutical, agrochemical and speciality chemical industries. The companys service portfolio includes basic research, library syntheses, process development, scale-up and small and large batch manufacturing. The company has a portfolio of over 27000 compounds and over 3000 IP protected compounds through Manchester Organics, its UK subsidiary. NFILs custom synthesis services are offered mainly through its UK subsidiary Manchester Organics. The company claims to have experience in developing fluoro similars and various fluorochemical analogues of lead compounds and libraries. They offer custom synthesis and contract research services through both FFS and FTE arrangements. NFIL has a cGMP manufacturing facility in India, to cater to mg - ton scale requirements.

Recognitions & Rankings of NFIL

India's Most Valuable Companies 2025 edition · Source: Hurun India
Valuation
₹34,950 Cr
1-year change
+100%
2024 #322 2023 #241 2022 #182
  • Headquarters Mumbai, India
  • Employees 2,670
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website nfil.in
  • Social LinkedIn Facebook
  • Legal Name Navin Fluorine International Limited
Key Metrics
  • Market Cap
    ₹50,365 Cr

    NAVINFLUOR · NSE

  • Share Price
    ₹10,278.00

    +4.72% today

  • Revenue
    ₹3,314 Cr

    FY 2025-26 · +41.1% YoY

  • EBITDA
    ₹1,075 Cr

    Margin 32.4%

  • Net Profit
    ₹648 Cr

    FY 2025-26 · +148.9% YoY

  • P/E (TTM)
    55.4x

    P/B 11.4x

  • ROE
    20.1%

    ROCE 20.4%

  • Debt / Equity
    0.41

    Interest cover 12.7x

  • Employee Count
    2,670

Board of directors of Navin Fluorine International Limited (NFIL)

Navin Fluorine International Limited is the primary company behind NFIL. The boards of the 2 registered companies of NFIL currently have 14 directors; the longest-serving is Sunil Siddharth Lalbhai, appointed in 2003. 29 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sunil Siddharth Lalbhai
DIN 00045590
Director03 Mar 200323 yrs 8 moNavin Fluorine International Limited
Niraj Mankad
DIN 00051259
Director06 Feb 20206 yrs 9 moNavin Fluorine Advanced Sciences Limited, Navin Fluorine International Limited
Ashok Sinha
DIN 00070477
Director28 Oct 20206 yrsNavin Fluorine International Limited
Atul Kumar Srivastava
DIN 00046776
Director07 Oct 20215 yrs 1 moNavin Fluorine Advanced Sciences Limited, Navin Fluorine International Limited
Apurva Purohit
DIN 00190097
Director19 Oct 20215 yrsNavin Fluorine International Limited
Akshika Raj Shah
DIN 09542943
Whole-time director28 Mar 20224 yrs 7 moNavin Fluorine Advanced Sciences Limited, Navin Fluorine International Limited
Vishad Padmanabh Mafatlal
DIN 00011350
Whole-time director01 Sep 20224 yrs 2 moNavin Fluorine Advanced Sciences Limited, Navin Fluorine International Limited
Sujal Anil Shah
DIN 00058019
Director14 Dec 20223 yrs 11 moNavin Fluorine Advanced Sciences Limited, Navin Fluorine International Limited
Anish Pravinkumar Ganatra
DIN 10074681
Whole-time director18 Mar 20233 yrs 8 moNavin Fluorine Advanced Sciences Limited, Navin Fluorine International Limited
Sudhir Ramchandra Deo
DIN 01122338
Director28 Sep 20233 yrs 1 moNavin Fluorine International Limited
Pradip Narotam Kapadia
DIN 00078673
Director30 Oct 20233 yrsNavin Fluorine Advanced Sciences Limited
Abhijit Jagdish Joshi
DIN 07115673
Director07 May 20242 yrs 6 moNavin Fluorine International Limited
Nitin Ganpati Kulkarni
DIN 03042587
Managing Director24 Jun 20242 yrs 4 moNavin Fluorine Advanced Sciences Limited, Navin Fluorine International Limited
Kartikeya Dube
DIN 00929373
Director03 Dec 202511 moNavin Fluorine International Limited

People of NFIL

59 people are tracked at NFIL (28 in leadership, 31 in team); the tracked headcount is 2,670.

NameRoleGroup
Debabrata Bhowmik
President- Technology &designLeadership
Dhruvajyoti Chakraborty
BU HR Head.Leadership
Gyanchand Jain
President of Strategic InitiativesLeadership
President of Legal and Company secretaryLeadership
P.S. Haridas
President of Supply Chain ManagementLeadership
Ambuj Mishra
Senior Director- Technical Business Head- Performance MaterialsLeadership
CFOLeadership
Manish Kabra
Head - Fp&a And ControllerLeadership
Janakiraman Rajaraman
Chief Supply Chain OfficerLeadership
Radheshyam Singh
President of OperationsLeadership
Rajendra Sahu
President of OperationsLeadership
Partha Roychowdhury
CEO, HPP BusinessLeadership
Jatin Swadas
Deputy General Manager ProcurementLeadership
Sadvik Badam
Director FinanceLeadership
Debargha Sarkar
Associate Director- Sales And Business DevelopmentLeadership
Amol D More
General Manager Human ResourcesLeadership
Sheetal Shetty
Head (Associate Director) - Talent AcquisitionLeadership
Ranjeet Singh
President And Chief Commercial Office-high Performance Products BusinessLeadership
Rohit Ranjan
Associate Director- HR & TQMLeadership
Sonu Singh
Director - Technology & DesignLeadership

39 more people are available in the full profile.

Premium access

Complete people profiles for NFIL

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of NFIL

NFIL is a publicly listed company on the NSE with ticker symbol NAVINFLUOR in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date01 Jun 2007
  • Listed onNSE: NAVINFLUOR
  • Listed entityNavin Fluorine International Limited
  • Exchange sectorProcess industries
  • ISININE048G01026
  • Share price₹8,532.00 (+0.76% on the day) · 2026-10-14
  • Market capitalisation₹43,440 Cr
  • Price to earnings55.4
  • EPS (diluted, trailing year)₹153.97
  • Dividend yield0.18%
  • Volume (last session)31,026

Financials of NFIL

Exchange-reported figures of Navin Fluorine International Limited, the listed company behind NFIL (NSE: NAVINFLUOR).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹3,314 Cr
+41.1% YoY
EBITDA
₹1,075 Cr
+101.4% YoY
Profit After Tax
₹648 Cr
+148.9% YoY
Net Worth
₹3,975 Cr
+51.3% YoY
Total Assets
₹5,474 Cr
+29.1% YoY
Total Debt
₹1,272 Cr
-13.3% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue3,3142,3492,0652,0771,4531,1791,062
Revenue growth+41.1%+13.8%-0.6%+42.9%+23.2%+11.1%-
EBITDA1,075534398550355309263
EBITDA margin+32.4%+22.7%+19.3%+26.5%+24.4%+26.2%+24.8%
Profit before tax873380336496344358258
Net profit648260233367264246406
Net profit margin+19.6%+11.1%+11.3%+17.7%+18.1%+20.8%+38.2%
EPS (β‚Ή)129.4758.1854.5975.7253.0952.0282.58
Balance sheet
Total assets5,4744,2403,8543,0741,9921,6841,453
Net worth3,9752,6262,3832,1851,8441,6341,412
Total debt1,2721,4661,36886112125.061.40
Cash & bank96.8740.5227.5434.8195.83544278
Net working capital793602609933542918534
Cash flow
Cash from operations894571750(63.59)74.76237157
Cash from investing(1,235)(511)(1,094)(656)(172)(237)85.14
Cash from financing344(46.70)33665841.50(45.05)(80.92)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue1,045938892758725701606519
Revenue growth (YoY)+44.1%+33.8%+47.2%+46.3%+38.5%---
Other income35.0931.3115.5818.2113.9111.8310.4811.16
EBITDA357321287246207179147107
EBITDA margin+34.2%+34.2%+32.2%+32.5%+28.5%+25.5%+24.3%+20.7%
Depreciation41.6841.2236.1636.5835.2435.2629.5627.90
Interest32.1228.9428.2630.3030.3528.2620.2113.86
Profit before tax31828223819815512710876.75
Tax75.0569.6852.8649.1337.9432.0424.4217.93
Net profit24321318514811794.9883.6058.82
EPS (β‚Ή)47.3941.4336.1329.0223.5919.1316.8411.85
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue2,3021,6871,4211,6281,4041,1331,022
Revenue growth+36.5%+18.7%-12.7%+16.0%+23.9%+10.8%-
EBITDA657339236422355311261
EBITDA margin+28.5%+20.1%+16.6%+25.9%+25.3%+27.4%+25.5%
Profit before tax656321292418347410257
Net profit472214195304267251397
Net profit margin+20.5%+12.7%+13.8%+18.7%+19.0%+22.1%+38.8%
EPS (β‚Ή)95.1648.7847.4663.0753.7760.4580.81
Balance sheet
Total assets3,7772,5842,3962,1821,9071,6901,420
Net worth3,6662,4972,3022,1411,8641,6501,389
Total debt43.8757.9264.4413.9916.0614.370.00
Cash & bank64.876.966.4313.9878.17389258
Net working capital451336529788798760506
Cash flow
Cash from operations511261556152237296155
Cash from investing(1,129)(183)(517)(157)(181)(345)76.67
Cash from financing626(76.31)(45.99)(59.29)(57.96)(43.56)(75.70)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue695627570562543485440386
Revenue growth (YoY)+28.0%+29.2%+29.6%+45.8%+44.3%---
Other income35.8431.2519.8733.4514.8711.9511.0812.46
Total expenses450443428397389373348314
EBITDA24518414216515411291.7471.74
EBITDA margin+35.3%+29.3%+24.9%+29.3%+28.4%+23.1%+20.9%+18.6%
Depreciation21.1022.3219.1419.7618.8018.8317.3917.10
Interest4.882.802.162.080.840.550.661.29
Profit before tax25519014117714910484.7765.81
Tax64.2054.6634.7242.5436.6727.8819.5315.76

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 18 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue1,045938892758725701606519
Revenue growth (YoY)+44.1%+33.8%+47.2%+46.3%+38.5%---
Other income35.0931.3115.5818.2113.9111.8310.4811.16
EBITDA357321287246207179147107
EBITDA margin+34.2%+34.2%+32.2%+32.5%+28.5%+25.5%+24.3%+20.7%
Depreciation41.6841.2236.1636.5835.2435.2629.5627.90
Interest32.1228.9428.2630.3030.3528.2620.2113.86
Profit before tax31828223819815512710876.75
Tax75.0569.6852.8649.1337.9432.0424.4217.93
Net profit24321318514811794.9883.6058.82
EPS (β‚Ή)47.3941.4336.1329.0223.5919.1316.8411.85
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue3,3142,3492,0652,0771,4531,1791,062
Revenue growth+41.1%+13.8%-0.6%+42.9%+23.2%+11.1%-
Other income65.2943.7310835.7339.2294.5533.33
Total expenses2,2391,8161,6671,5271,099870798
Employee cost307297286249182142131
EBITDA1,075534398550355309263
EBITDA margin+32.4%+22.7%+19.3%+26.5%+24.4%+26.2%+24.8%
Depreciation14911996.1662.6447.9044.1737.00
Interest11877.9374.5627.521.901.842.00
Profit before tax873380336496344358258
Tax21091.4965.0312181.15111(144)
Net profit648260233367264246406
Net profit margin+19.6%+11.1%+11.3%+17.7%+18.1%+20.8%+38.2%
EPS (β‚Ή)129.4758.1854.5975.7253.0952.0282.58
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital10.259.929.919.919.919.909.90
Reserves & surplus3,9642,6162,3732,1751,8341,6241,402
Shareholders' funds (net worth)3,9752,6262,3832,1851,8441,6341,412
Minority interest0.000.000.000.000.000.000.00
Secured loans1,2261,4411,3408491042.521.40
Unsecured loans45.4025.6628.5212.1516.3522.540.00
Total debt1,2721,4661,36886112125.061.40
Total liabilities5,4744,2403,8543,0741,9921,6841,453
Assets
Gross block3,8983,1802,2031,899749694642
Net block3,3242,7361,8751,646556540529
Capital work in progress14335571127974294.8738.85
Investments1,22948049543.8111899.08195
Inventories446322372468258180158
Sundry debtors752582513562358284218
Cash & bank balances96.8740.5227.5434.8195.83544278
Loans & advances26717215528920410255.93
Total current assets1,5621,1171,0671,3539151,110710
Total current liabilities769515458420373193176
Net working capital793602609933542918534
Total assets5,4744,2403,8543,0741,9921,6841,453
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash19.686.6414.4775.7413217715.87
Net cash from operating activities894571750(63.59)74.76237157
Net cash from investing activities(1,235)(511)(1,094)(656)(172)(237)85.14
Net cash from financing activities344(46.70)33665841.50(45.05)(80.92)
Net change in cash2.8713.04(7.83)(61.27)(56.11)(44.88)161
Closing cash96.8740.5227.5434.8195.83544278
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+41.1%+13.8%-0.6%+42.9%+23.2%+11.1%-
EBITDA growth+101.4%+34.0%-27.6%+55.1%+14.7%+17.4%-
PBT growth+129.7%+13.3%-32.3%+44.1%-3.8%+38.8%+14.9%
Net income growth+148.9%+11.7%-36.4%+39.2%+7.3%-39.4%-
Revenue CAGR (3Y)+16.8%+17.4%+20.5%+25.1%+13.4%+8.9%+12.7%
EBITDA CAGR (3Y)+25.0%+14.6%+8.8%+27.8%+17.6%+12.9%+18.4%
Profitability & leverage
Net income margin+20.0%+12.3%+13.1%+18.1%+18.1%+21.0%+37.8%
Return on capital employed+20.4%+11.3%+10.4%+20.7%+18.8%+22.9%+20.4%
Return on net worth+20.1%+11.5%+10.2%+18.6%+15.1%+16.2%+32.3%
Debt / equity0.410.570.490.240.040.010.00
Long-term debt / equity0.310.420.390.220.040.010.00
Interest cover12.7318.8124.685.640.620.690.88
Efficiency & per share
Fixed asset turnover0.940.871.011.572.011.771.84
Inventory turnover8.636.774.925.736.646.977.87
Debtors turnover4.974.293.854.524.534.695.43
EPS (β‚Ή)129.4758.1854.5975.7253.0952.0282.58
Dividend per share (β‚Ή)8.607.0015.0012.0011.0011.0011.00
Book value per share (β‚Ή)775.53529.48480.86440.96372.19330.03285.42
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue695627570562543485440386
Revenue growth (YoY)+28.0%+29.2%+29.6%+45.8%+44.3%---
Other income35.8431.2519.8733.4514.8711.9511.0812.46
Total expenses450443428397389373348314
EBITDA24518414216515411291.7471.74
EBITDA margin+35.3%+29.3%+24.9%+29.3%+28.4%+23.1%+20.9%+18.6%
Depreciation21.1022.3219.1419.7618.8018.8317.3917.10
Interest4.882.802.162.080.840.550.661.29
Profit before tax25519014117714910484.7765.81
Tax64.2054.6634.7242.5436.6727.8819.5315.76
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue2,3021,6871,4211,6281,4041,1331,022
Revenue growth+36.5%+18.7%-12.7%+16.0%+23.9%+10.8%-
Other income87.5355.5412041.0037.4714131.34
Total expenses1,6451,3481,1851,2061,048822762
Employee cost221218210203153116117
EBITDA657339236422355311261
EBITDA margin+28.5%+20.1%+16.6%+25.9%+25.3%+27.4%+25.5%
Depreciation80.0269.8857.5842.6044.2540.6733.74
Interest7.883.194.962.051.661.421.60
Profit before tax656321292418347410257
Tax16979.3757.3010680.55110(143)
Net profit472214195304267251397
Net profit margin+20.5%+12.7%+13.8%+18.7%+19.0%+22.1%+38.8%
EPS (β‚Ή)95.1648.7847.4663.0753.7760.4580.81
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital10.259.929.919.919.919.909.90
Reserves & surplus3,6562,4872,2922,1311,8541,6401,379
Shareholders' funds (net worth)3,6662,4972,3022,1411,8641,6501,389
Secured loans0.1034.9639.650.000.000.000.00
Unsecured loans43.7722.9624.7913.9916.0614.370.00
Total debt43.8757.9264.4413.9916.0614.370.00
Total liabilities3,7772,5842,3962,1821,9071,6901,420
Assets
Gross block1,2971,113938684604544519
Net block906783672468429403413
Capital work in progress64.4454.2145.4115425.8836.5338.85
Investments2,3591,4201,154736619450296
Inventories199169215327229154136
Sundry debtors600442320393352276209
Cash & bank balances64.876.966.4313.9878.17389258
Loans & advances13760.4228525833810156.85
Total current assets1,002678827991998921660
Total current liabilities552343298204200160154
Net working capital451336529788798760506
Total assets3,7772,5842,3962,1821,9071,6901,420
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash3.061.699.0973.5176.0716912.70
Net cash from operating activities511261556152237296155
Net cash from investing activities(1,129)(183)(517)(157)(181)(345)76.67
Net cash from financing activities626(76.31)(45.99)(59.29)(57.96)(43.56)(75.70)
Net change in cash7.461.37(7.40)(64.42)(2.56)(93.08)156
Closing cash64.876.966.4313.9878.17389258
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+36.5%+18.7%-12.7%+16.0%+23.9%+10.8%-
EBITDA growth+93.8%+43.9%-44.2%+18.7%+14.3%+19.2%-
PBT growth+104.3%+9.9%-30.1%+20.5%-15.3%+59.5%+13.3%
Net income growth+121.0%+9.5%-35.8%+14.0%+6.6%-36.9%-
Revenue CAGR (3Y)+12.2%+6.3%+7.8%+16.8%+13.7%+9.0%+13.7%
EBITDA CAGR (3Y)+15.9%-1.6%-8.8%+17.4%+17.7%+13.8%+20.3%
Profitability & leverage
Net income margin+21.2%+14.3%+16.6%+19.2%+19.0%+26.4%+39.1%
Return on capital employed+20.9%+13.0%+10.6%+20.6%+19.4%+22.0%+20.7%
Return on net worth+15.8%+10.1%+8.8%+15.6%+15.2%+16.5%+32.7%
Debt / equity0.020.030.020.010.010.000.00
Long-term debt / equity0.010.010.010.010.010.000.00
Interest cover1.371.192.790.540.530.530.70
Efficiency & per share
Fixed asset turnover1.911.651.752.532.442.132.23
Inventory turnover12.508.805.245.857.317.808.93
Debtors turnover4.424.433.994.374.474.675.43
EPS (β‚Ή)95.1648.7847.4663.0753.7760.4580.81
Dividend per share (β‚Ή)8.607.0015.0012.0011.0011.0011.00
Book value per share (β‚Ή)715.27503.50464.54432.09376.23333.31280.72

Web traffic of NFIL

The website of NFIL (nfil.in) receives about 10.5K visits a month.

  • Monthly visits
    10.5K

    ▲ 49.5% vs previous month

Similar websites

Websites whose visitors overlap most with NFIL. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
nesco.in
91%
21.7K#1,041,485View details

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as NFIL (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Nfil

NAVINFLUOR: RS. 50.37 CRORES NSE BLOCK TRADE; FOR ~ 50,497 SHARES, AT RS. 9975.50
Exchange Update β€’ 2 days ago
NAVINFLUOR: Q2 EBITDA 4.1B RUPEES VS 2.46B (YOY); Q2 EBITDA MARGIN 34.22% VS 32.46% (YOY)
Exchange Update β€’ 19 days ago
NAVINFLUOR: Q2 CONS NET PROFIT 2.7B RUPEES VS 1.48B (YOY); EST 2.3B
Exchange Update β€’ 19 days ago
Navin Fluorine International: Announces Interim Dividend of ₹8 for Each Share.
Exchange Update β€’ 19 days ago
Navin Fluorine International: Will Meet Analysts And Investors On October 12.
Exchange Update β€’ 1 month ago
Navin Fluorine International: Begins Commercial Production And Dispatch At Dahej After Successful Debottlenecking Of Multi-Purpose Plant Today.
Exchange Update β€’ 1 month ago
NAVINFLUOR: Rs. 44.39 Crores BSE Block Trade; for ~ 53,000 Shares, at Rs. 8375.00
Exchange Update β€’ 1 month ago
Premium access

Complete news archive for NFIL

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about NFIL

NFIL was founded in 1967.

NFIL is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

NFIL has 2,670 employees.

The primary company behind NFIL, Navin Fluorine International Limited, reported revenue of β‚Ή3,379 Cr for FY 2026, up 41% year on year.

Navin Fluorine International Limited (NFIL) is a CRAMS company engaged in the research and synthesis of fluorinated compounds for the pharmaceutical, agrochemical and speciality chemical industries. The companys service portfolio includes basic research, library syntheses, process development, scale-up and small and large batch manufacturing. The company has a portfolio of over 27000 compounds and over 3000 IP protected compounds through Manchester Organics, its UK subsidiary. NFILs custom synthesis services are offered mainly through its UK subsidiary Manchester Organics. The company claims to have experience in developing fluoro similars and various fluorochemical analogues of lead compounds and libraries. They offer custom synthesis and contract research services through both FFS and FTE arrangements. NFIL has a cGMP manufacturing facility in India, to cater to mg - ton scale requirements.

Yes, NFIL is publicly traded on NSE under the ticker symbol NAVINFLUOR.

NFIL is associated with 2 legal entities: Navin Fluorine International Limited, Navin Fluorine Advanced Sciences Limited.

The legal entities of NFIL currently have 17 directors, including Vishad Padmanabh Mafatlal, Sujal Anil Shah, Niraj Mankad and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available